Requiring FDA Guidances Does Not Always Advance The Science, Gene Therapy Director Says

 
• By Derrick Gingery
  
Cell therapy
The FDA's infusion of user fee capital for cell and gene therapy work likely will take years to create an impact. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies